Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Integrated Treatment to Persons With Mental Disorders and co-Occurring Substance Use Disorders (ROP)
This study is currently recruiting participants.
Verified by SINTEF Health Research, March 2007
Sponsors and Collaborators: SINTEF Health Research
The Research Council of Norway
University of Oslo
Information provided by: SINTEF Health Research
ClinicalTrials.gov Identifier: NCT00447733
  Purpose

The purpose of this study is to determine whether integrated treatment is effective in the treatment of mental disorders and co-occurring substance use disorders.


Condition Intervention Phase
Anxiety Disorders
Mood Disorders
Substance Use Disorders
Behavioral: Integrated mental health and substance misuse treatment
Phase II
Phase III

MedlinePlus related topics: Anxiety Mental Health
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Effects of Integrated Treatment to Persons With Mental Disorders and co-Occurring Substance Use Disorders

Further study details as provided by SINTEF Health Research:

Primary Outcome Measures:
  • alcohol and drug use at baseline, six and twelve months
  • Psychopathology at baseline, six and twelve months
  • Global functioning at baseline, six and twelve months

Secondary Outcome Measures:
  • Quality of life at baseline, six and twelve months
  • Therapist alliance at six and twelve months
  • Treatment fidelity at six and twelve months

Estimated Enrollment: 150
Study Start Date: April 2007
Estimated Study Completion Date: December 2008
Detailed Description:

Patients with mental disorders and co-occuring substance use disorders are characterized by high suicide and treatment drop-out rates, and long-lasting interpersonal, work, school, health and legal problems. And because mental disorders and substance use disorders interact and co-exists, it may be important to provide treatment that integrates their substance misuse and mental health problems in a comprehensive way. The health services for patients with mental health and substance use disordes are usually provided by different services and health professionals that rarely cooperate or have qualifications on both kinds of disorders. The over-all aim of the study is to evaluate the effects of evidence-based integrated and comprehensive treatment of mental health problems and co-occurring substance use disorders. The effects of the treatment will be assesses on substance use,psychopathology, and quality of life.

Comparison: patients receiving treatment-as-usual or non-manualized treatment at general mental health outpatients clinics.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • clinical diagnosis of substance use disorder
  • clinical diagnosis of anxiety disorders
  • clinical diagnosis of nonpsychotic mood disorders
  • written consent
  • planning to live in the catchment area during the treatment

Exclusion Criteria:

  • schizophrenia spectrum disorders
  • other psychotic disorders
  • mental retardation
  • having nicotine abuse/dependency only
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00447733

Contacts
Contact: Rolf W. Grawe, Ph.D 92221971 ext 47 rolf.w.grawe@sintef.no
Contact: Linda Wusthoff, cand.med. 90569834 ext 47 lindawusthoff@hotmail.com

Locations
Norway
University of Oslo; Institute of Psychiatry Recruiting
Oslo, Norway, 0318
Contact: Linda Wusthoff, cand.med.     90569834 ext 47     lindawusthoff@hotmail.com    
Contact: Helge Waal     23368935 ext 47     helge.waal@uio.medisin.no    
Principal Investigator: Linda Wusthoff, cand.med            
Sponsors and Collaborators
SINTEF Health Research
The Research Council of Norway
University of Oslo
Investigators
Principal Investigator: Rolf W. Gråwe, Ph.D SINTEF Health Research
  More Information

substance abuse treatment for persons with co-occurring disorders  This link exits the ClinicalTrials.gov site

Study ID Numbers: 78i068, NFR175394/V50
Study First Received: March 14, 2007
Last Updated: April 24, 2007
ClinicalTrials.gov Identifier: NCT00447733  
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by SINTEF Health Research:
mental health
substance use
treatment

Study placed in the following topic categories:
Anxiety Disorders
Mental Disorders
Substance-Related Disorders
Mood Disorders
Disorders of Environmental Origin

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 16, 2009